“…Second, although biomarkers (e.g., EEG, MRI) may potentially be more sensitive to group differences before behavioral differences are evident (Bosl et al, 2018;Shen et al, 2013Shen et al, , 2017Emerson et al, 2017;Hazlett et al, 2017), they are unlikely to be scalable or used universally in community-based settings. Third, there may be significant overlap between prodromal symptoms across neurodevelopmental disorders and child psychopathology more broadly (e.g., ASD, ADHD, anxiety) which may wax and wane across development (Begum Ali et al, 2020;Hatch et al, 2020;Miller et al, in press;Shephard et al, 2019), calling into question the specificity and longterm predictive validity of these tools and ultimately necessitating the shift to a transdiagnostic perspective.…”